Novel Dosing Regimen of Eptifibatide in Planned Coronary Stent Implantation (ESPRIT): A Randomized, Placebo-Controlled Trial - ESPRIT 30 Day Results

Description:

Novel Dosing Regimen of Eptifibatide in Planned Coronary Stent Implantation (ESPRIT): A Randomized, Placebo-Controlled Trial.